C section News and Research

RSS

Rexahn's RX-5902 pre-clinical data against cancer to be presented at AACR Annual Meeting

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-5902 during a poster session at the American Association for Cancer Research 102nd Annual Meeting being held in Orlando, Florida, April 2-6, 2011, at the Orange County Convention Center.

31 Mar 2011

New clinical practice guidelines developed for juvenile idiopathic arthritis

The American College of Rheumatology has developed new guidelines for starting and monitoring treatments for children with juvenile idiopathic arthritis. These are the first JIA guidelines endorsed by the ACR, with the goal of broad acceptance within the rheumatology community.

30 Mar 2011

Study: Increasing Medicare age would shift costs

A study released today concluded that employers and younger people would end up paying more for their health insurance if Medicare's eligibility age were raised. However, the age change would also result in billions of dollars in taxpayer savings.

30 Mar 2011

Onyx plans to expand carfilzomib Phase 3 European trial in patients with myeloma

Onyx Pharmaceuticals, Inc. today announced its plans to expand the Phase 3 European clinical trial FOCUS, which is evaluating the efficacy and tolerability of carfilzomib, a selective next-generation proteasome inhibitor.

29 Mar 2011

Cephalon intends to make takeover bid for ChemGenex

Cephalon, Inc. and ChemGenex Pharmaceuticals Limited today jointly announced that Cephalon's wholly-owned subsidiary, Cephalon CXS Holdings Pty Ltd, intends to make a takeover bid for ChemGenex.

29 Mar 2011

Medtronic's Resolute drug-eluting stent pivotal U.S. data to be presented at ACC.11

Medtronic, Inc., today announced the imminent release of the pivotal U.S. data on its Resolute drug-eluting stent at ACC.11, the 60th Annual Scientific Session & Expo of the American College of Cardiology, which takes place April 2-5 in New Orleans.

29 Mar 2011

USPTO issues Notice of Allowance to Modular's green surfactant patent application

Modular Genetics, Inc. is a sustainable chemistry company utilizing advanced technology in synthetic biology to produce specialty chemicals that are cost competitive, provide superior performance and are environmentally friendly. Modular's lead product is a "green" surfactant initially targeting the personal care market.

29 Mar 2011

Dosing commences in Phase I clinical study of GenSpera's G-202 at Cancer Therapy & Research Center

GenSpera, Inc. announced that the first patient was dosed in the ongoing Phase I clinical study of its chemotherapeutic agent, G-202, at the Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio in San Antonio, Texas.

28 Mar 2011

Medwell acquires ownership and control over 6,449,501 common shares of Spectral

Spectral Diagnostics Inc., a Phase III company developing the first theranostic treatment for severe sepsis and septic shock, and Medwell Capital Corp., today jointly announced a non-brokered agreement whereby Medwell and a consortium of buyers purchased in private transactions 12,449,501 common shares and 962,500 common share purchase warrants of Spectral from GrowthWorks Canadian Fund Ltd., representing 15.6% of the issued and outstanding shares.

28 Mar 2011

Moving quickly across slippery surfaces reduces chances of falling

Biomechanics researchers Timothy Higham of Clemson University and Andrew Clark of the College of Charleston conclude that moving quickly in a forward, firm-footed stance across a slippery surface is less likely to lead to a fall than if you move slowly. Approaching a slippery surface slowly hinders the necessary task of shifting the center of mass forward once foot contact is made.

25 Mar 2011

As states consider abortion measures, South Dakota law becomes flashpoint

The ramifications of this South Dakota law may be more political than practical, reports Politico, while people on both sides of the issue spring into action.

25 Mar 2011

Pharmacists seek delay of rule limiting amount of dispensed drugs

The National Community Pharmacists Association is pressuring Medicare officials to delay a regulation that they say will drive up labor costs for drug stores and increase the potential for dispensing errors. The proposed rule is expected to be finalized and take effect on Jan. 1, 2012.

24 Mar 2011

Little evidence supporting effectiveness of acupuncture in reducing pain

Although acupuncture is commonly used for pain control, doubts about its effectiveness and safety remain. Investigators from the Universities of Exeter & Plymouth (Exeter, UK) and the Korea Institute of Oriental Medicine (Daejeon, South Korea) critically evaluated systematic reviews of acupuncture as a treatment of pain in order to explore this question.

24 Mar 2011

Star Scientific's Ariva-BDL and Stonewall-BDL modified risk tobacco products not subject to FDC Act Chapter IX

Star Scientific, Inc. announced that the company has received notices from the Food and Drug Administration (FDA) regarding its pending ARIVA-BDL™ and STONEWALL-BDL™ modified risk tobacco product applications.

24 Mar 2011

Sequencing mouse cancer genome reveals mutations driving cancer in humans

Scientists who pioneered sequencing the genomes of cancer patients to find novel genetic changes at the root of the disease now have turned their attention to a laboratory workhorse — a mouse.

24 Mar 2011

Scientists reveal protein target that can trigger myocarditis

People with type 1 diabetes, whose insulin-producing cells have been destroyed by the body's own immune system, are particularly vulnerable to a form of inflammatory heart disease caused by a different autoimmune reaction.

24 Mar 2011

Tick-borne disease identified as emerging threat

Five years ago, large numbers of farmers in central China began falling victim to an mysterious disease marked by high fever, gastrointestinal disorder and an appalling mortality rate - as high as 30 percent in initial reports. Investigators from the Chinese Center for Disease Control and Prevention hurried to the scene of the outbreak. On the basis of DNA evidence, they quickly concluded that it had been caused by human granulocytic anaplasmosis, a bacteria transmitted by tick bites.

24 Mar 2011

C section News and Research

Rexahn's RX-5902 pre-clinical data against cancer to be presented at AACR Annual Meeting

New clinical practice guidelines developed for juvenile idiopathic arthritis

Study: Increasing Medicare age would shift costs

Onyx plans to expand carfilzomib Phase 3 European trial in patients with myeloma

Cephalon intends to make takeover bid for ChemGenex

Medtronic's Resolute drug-eluting stent pivotal U.S. data to be presented at ACC.11

USPTO issues Notice of Allowance to Modular's green surfactant patent application

Dosing commences in Phase I clinical study of GenSpera's G-202 at Cancer Therapy & Research Center

Medwell acquires ownership and control over 6,449,501 common shares of Spectral

Moving quickly across slippery surfaces reduces chances of falling

As states consider abortion measures, South Dakota law becomes flashpoint

Pharmacists seek delay of rule limiting amount of dispensed drugs

Little evidence supporting effectiveness of acupuncture in reducing pain

Star Scientific's Ariva-BDL and Stonewall-BDL modified risk tobacco products not subject to FDC Act Chapter IX

Sequencing mouse cancer genome reveals mutations driving cancer in humans

Scientists reveal protein target that can trigger myocarditis

Tick-borne disease identified as emerging threat

California insurers reduce, delay planned rate increases

Study to measure lower pressure's impact on kidney disease, cognitive function

Analysis of the past, predictions for the future mark health law's first anniversary

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News